Clin Osteol 2004; 9(1): 16-17

A critical analysis of the WHI study from the point of view of prevention and management of osteoporosisArticles

J. Jeníček

The WHI study was done with a population that greatly differs from the current population ofmenopausal women. To apply its results in practice israther difficult. The mean age of the women was 63 years - and even the oldest women were given the same dose of conjugated estrogens (0.625 mg). For years now we have been administering to older women lower estrogen doses and, moreover, we have at our disposal preparations with modern ges­ tagens (dydrogesterone, dienogest) or tibolone.

Keywords: WHI, estrogens, tibolone, osteoporosis.

Published: June 11, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jeníček J. A critical analysis of the WHI study from the point of view of prevention and management of osteoporosis. Osteologický bulletin. 2004;9(1):16-17.
Download citation

References

  1. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333. Go to original source...
  2. Hays J, Ockene JK, Brunner RL, et al. Effectss of Estrogen plus Progestin on Health-Related Quality of Life. N Engl J Med 2003;348:1839-1854. Go to original source...
  3. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus Progestin and the Inci­ dence of Dementia and Mild Cognitive Impairment in Postmenopausal Women, The Womens' Health Initiative Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2651-2662. Go to original source...
  4. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of Estrogen plus Progestin on Global Cognitive Function in Postmenopausal Women, The Womens Health Initia­ tive Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2663-2671. Go to original source...
  5. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of Estrogen plus Pro­ gestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, The Womens Health Initiative Randomized Trial. JAMA 2003;289:3243-3253. Go to original source...
  6. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. WHI Investigators. Effect of Estrogen plus Progestin on Stroke in Postmenopausal Women, The Women's Health Initiative: a Randomized Trial. JAMA 2003;289:2673-2684. Go to original source...
  7. Hendrix Sl. Hormone therapy: evolving concepts. Curr Opin Rheumatol 2003; 15:464-8. Go to original source...
  8. Rymer J, Robinson J, Fogelman I. Ten years of treatment with tibolone 2,5 mg daily: effects on bone loss in postmenopausal women. Climacetric 2002;5:226-42. inzerát Biomin Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.